Libre, Hannah Hazel .

HRN: 27-96-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2026
CEFUROXIME 1.5GM (VIAL)
06/08/2026
06/09/2026
IV
1.5
Q8 For 3 Doses
Uti
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: